News
High-signal headlines only - macro events, earnings, M&A, regulatory. Listicles and analyst clickbait filtered out by default. Refreshed hourly.
105last 24h
3127last 7d
510● bullish (7d)
311● bearish (7d)
227publishers
CNW Group4d agobearish
Blue Chips Surge Past 2.8% as VIX Drops Below 18 While Oil Sinks Nearly 8%Insider Monkey42d agobearish
Amgen (AMGN) Sells its Deerfield Campus for $151 Million and Leases it BackMT Newswires61d agobearish
Amgen's Olpasiran May Still Show Heart-Risk Reduction Despite Novartis Miss, UBS Says24/7 Wall St.61d agobearish
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%GuruFocus.com61d agobearish
AstraZeneca Falls Today Even as Imfinzi Wins a Landmark Survival TestInvestorsHub61d agobearish
Amgen Shares Fall as Investors Assess Novartis Lp(a) Trial Result and BMO DowngradeBarrons.com64d agobearish
A Novartis Heart Drug Trial Stumbles. Can a Rare-Disease Treatment Lift Shares?Investor's Business Daily69d agobearish
One Of Amgen's Biggest Moneymakers Cuts The Risk Of Dying By 20%24/7 Wall St.87d agobearish
How to Build $7,200 a Month in Dividend Income Without Selling a Single ShareSimply Wall St.124d agobearish
Did Enbrel’s Price Cap Reprieve and New Recalls Just Rebalance Amgen’s (AMGN) Risk‑Reward Profile?